ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 479,40
-0,68%
Dow Jones
39 118,86
-0,12%
DAX
18 235,45
0,17%
Brent Oil
84,85
0,00%
Bitcoin
60 874,01
0,93%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. AMEX
  6. Maia Biotechnology Inc (MAIA)

  7. Maia Biotechnology Inc (MAIA) Actualités

MAIA

Maia Biotechnology (MAIA)

Maia Biotechnology Inc
De:
Trier par:
 Showing the most relevant articles for your search:AMEX:MAIA
DateHeureSourceTitreSymboleSociété
07/06/202418h31Business WireMAIA Biotechnology's Telomere Targeting Functionality is Shown Viable by FDA’s Approval of a Telomerase Inhibitor Agent TherapyAMEX:MAIAMaia Biotechnology Inc
06/06/202420h57Edgar (US Regulatory)Form 8-K - Current reportAMEX:MAIAMaia Biotechnology Inc
06/06/202416h07Business WireMAIA Biotechnology Announces Year-to-Date Achievements and Highlights Recent Clinical Progress for Novel Anticancer AgentAMEX:MAIAMaia Biotechnology Inc
04/06/202414h41Business WireMAIA Biotechnology Reveals New Clinical Data Showing THIO’s Strong Efficacy in Non-Small Cell Lung CancerAMEX:MAIAMaia Biotechnology Inc
17/05/202414h37Business WireMAIA Biotechnology to Present at the BIO International Convention 2024AMEX:MAIAMaia Biotechnology Inc
16/05/202414h37Business WireMAIA Biotechnology Abstract Accepted for Poster Presentation at American Society of Clinical Oncology (ASCO) 2024 Annual MeetingAMEX:MAIAMaia Biotechnology Inc
15/05/202422h05Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:MAIAMaia Biotechnology Inc
14/05/202422h11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:MAIAMaia Biotechnology Inc
30/04/202414h08Business WireMAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private PlacementAMEX:MAIAMaia Biotechnology Inc
29/04/202414h08Business WireMAIA Biotechnology Announces Share Purchase by Director Stan Smith, Ph.D. in Private PlacementAMEX:MAIAMaia Biotechnology Inc
23/04/202414h51Business WireMAIA Biotechnology Announces $1.00 Million Private PlacementAMEX:MAIAMaia Biotechnology Inc
05/04/202414h01Business WireMAIA Biotechnology to Present at Two Investor Conferences in April 2024AMEX:MAIAMaia Biotechnology Inc
28/03/202420h00Business WireMAIA Biotechnology Announces Share Purchases by Directors Cristian Luput and Ramiro GuerreroAMEX:MAIAMaia Biotechnology Inc
26/03/202413h01Business WireMAIA Biotechnology Announces $1.33 Million Private PlacementAMEX:MAIAMaia Biotechnology Inc
22/03/202420h00Business WireMAIA Biotechnology Announces Share Purchase by Director Stan Smith, PhD in a $2.9 Million Private PlacementAMEX:MAIAMaia Biotechnology Inc
21/03/202420h00Business WireMAIA Biotechnology Welcomes Prominent Medical Oncology Scientist Dr. Saadettin Kilickap to its Scientific Advisory BoardAMEX:MAIAMaia Biotechnology Inc
07/03/202415h45Business WireMAIA Biotechnology to Participate in the 36th Annual ROTH ConferenceAMEX:MAIAMaia Biotechnology Inc
06/03/202417h04Business WireMAIA Biotechnology and Nationwide Children’s Hospital Announce Presentation of THIO’s Potency in Pediatric Brain Tumors at American Association of Cancer Research Annual MeetingAMEX:MAIAMaia Biotechnology Inc
06/03/202414h48Business WireMAIA Biotechnology Announces Strong Efficacy of THIO as Third-Line Treatment for Non-Small Cell Lung Cancer PatientsAMEX:MAIAMaia Biotechnology Inc
05/03/202414h45Business WireMAIA Biotechnology CEO Details Immuno-Oncology Cancer Treatment Candidates and Development Pipeline in Letter to ShareholdersAMEX:MAIAMaia Biotechnology Inc
07/02/202414h01Business WireMAIA Biotechnology Announces Publication in Nature Communications on Positive Effects of THIO for Potential Treatment of Small Cell Lung CancerAMEX:MAIAMaia Biotechnology Inc
26/01/202422h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:MAIAMaia Biotechnology Inc
24/01/202413h15Business WireMAIA Biotechnology Announces Publication of International PCT Patent Application Covering Anticancer Telomere-Targeting CompoundsAMEX:MAIAMaia Biotechnology Inc
20/01/202403h00Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesAMEX:MAIAMaia Biotechnology Inc
17/01/202415h00Business WireMAIA Biotechnology Provides Positive Phase 2 Clinical Updates for Lead Anticancer Agent and Outlines Targeted Milestones for 2024AMEX:MAIAMaia Biotechnology Inc
05/01/202414h00Business WireMAIA Biotechnology to Present at Biotech Showcase 2024 on January 9, 2024AMEX:MAIAMaia Biotechnology Inc
19/12/202313h00Business WireMAIA Biotechnology Announces Dose Selection in THIO-101 Phase 2 Clinical Trial for Non-Small Cell Lung CancerAMEX:MAIAMaia Biotechnology Inc
29/11/202322h19Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesAMEX:MAIAMaia Biotechnology Inc
20/11/202322h31Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:MAIAMaia Biotechnology Inc
17/11/202321h52Business WireMAIA Biotechnology Announces Closing of $4 Million Registered Direct OfferingAMEX:MAIAMaia Biotechnology Inc
 Showing the most relevant articles for your search:AMEX:MAIA

Dernières Valeurs Consultées

NYSE
DIS
Walt Disney
EU
PX1
CAC 40
EU
SGO
Cie de SaintGobain
SPI
SP500
S&P 500
FTSE
UKX
FTSE 100
EU
AI
Air Liquide
NYSE
MCD
McDonalds
NYSE
JPM
JP Morgan Chase
EU
VIV
Vivendi
EU
VK
Vallourec
EU
AF
Air FranceKLM
EU
ML
Michelin
EU
ORA
Orange
EU
ACA
Credit Agricole
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés